Nursing of chemotherapy-induced myelosuppression.doc

 PAGE \* MERGEFORMAT 7 Nursing of chemotherapy-induced myelosuppression [Abstract] This paper summarizes malignant bone marrow suppression after chemotherapy nursing, concluded that: the strict observation and appropriate care and treatment, can suppress the bone marrow through bone marrow suppression in patients with a variety of adverse reactions. [Keywords:] myelosuppressive chemotherapy care Bone marrow suppression is the bone marrow precursors of blood cells were decreased. Bloodstream in the red blood cells and white blood cells are derived from bone marrow stem cells. Blood flow in the short life of blood cells, and often need to continue to add. In order to replenish the purpose, as precursors of blood cells to rapidly dividing stem cells. Chemical Treatment (Chemotherapy and radiation therapy (radiation and many other anti-tumor therapy, are directed at rapidly dividing cells, which often leads to suppression of normal bone marrow cells. Bone marrow suppression is the most common chemotherapy major limiting toxicity. myelosuppression after chemotherapy, mainly as decreased white blood cells and platelets. Most chemotherapy drugs can cause different degrees of bone marrow depression, the more common drugs such as: Adriamycin, Taxol, Carboplatin, different cyclophosphamide, Changchun, alkali and so on. myeloid average survival time for the shortest, about 6-8 hours, so often the first bone marrow depression manifested as leukopenia, thrombocytopenia average survival time is about 5-7 days, the decline appears more night light, and red blood cell survival time was 120 days on average, less affected by chemotherapy, a decrease is usually not obvious. Most of chemotherapy-induced bone marrow suppression, usually occurring 1-3 weeks after chemotherapy, some gradually recovered over 2-4 weeks , and mainly leukopenia, thrombocytopenia may have with a small number of drugs such as gemcitabine, carboplatin, mitomycin Zeyi thrombocytopenia based.